Otsuka Holdings Co., Ltd. is a leading pharmaceutical company based in Japan with a medium risk rating ESG score of 23.0. The company specializes in providing healthcare solutions in a variety of areas including nervous system, oncology, and cardiovascular system. Otsuka Holdings is also involved in the research and development of functional foods and beverages. Additionally, the company operates in multiple industries such as chemicals, transportation, and electronic equipment. Although Otsuka Holdings has a presence in North America and other regions, Japan remains the main source of revenue.